Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - ACCOUNTS PAYABLE
Accounts Payable KPTI - Karyopharm Therapeutics Inc.
5.11 M
LAST VALUE
35.71%
2 YEAR CAGR
38.98%
5 YEAR CAGR
-2.06%
10 YEAR CAGR